Ingevity Corporation (NGVT)
NYSE: NGVT · Real-Time Price · USD
70.27
+0.96 (1.39%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Ingevity Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,160 | 1,168 | 1,200 | 1,216 | 1,668 | 1,392 | |
Revenue Growth | -1.38% | -2.71% | -1.27% | -27.14% | 19.89% | 14.42% |
Cost of Revenue | 683.1 | 706.1 | 729 | 749.9 | 1,097 | 878.7 |
Gross Profit | 477.2 | 461.5 | 471.1 | 465.6 | 571 | 512.8 |
Selling, General & Admin | 165.5 | 171.3 | 157.7 | 162.1 | 198.3 | 179.1 |
Research & Development | 27.2 | 28.4 | 24.5 | 25.4 | 30.3 | 26.3 |
Operating Expenses | 192.7 | 199.7 | 182.2 | 187.5 | 228.6 | 205.4 |
Operating Income | 284.5 | 261.8 | 288.9 | 278.1 | 342.4 | 307.4 |
Interest Expense | -71 | -78.3 | -97.8 | -93.3 | -61.8 | -51.7 |
Interest & Investment Income | 5.3 | 5.2 | 7.7 | 6.3 | 7.5 | 4 |
Currency Exchange Gain (Loss) | -1.3 | 0.6 | -4.2 | -3.7 | -2.3 | -2.5 |
Other Non Operating Income (Expenses) | -5.4 | -5.9 | 155.8 | 22.9 | 3.5 | 7.4 |
EBT Excluding Unusual Items | 212.1 | 183.4 | 350.4 | 210.3 | 289.3 | 264.6 |
Merger & Restructuring Charges | -5.9 | -12.8 | -77.4 | -99.6 | -19.7 | -16.8 |
Impairment of Goodwill | - | -183.8 | -306.6 | - | - | - |
Gain (Loss) on Sale of Investments | -17.1 | -19.6 | -2.1 | 19.3 | - | - |
Asset Writedown | -144.2 | -109.3 | - | - | - | - |
Legal Settlements | -15.7 | - | - | - | - | -85 |
Other Unusual Items | - | - | -104.8 | - | - | - |
Pretax Income | 37.8 | -142.1 | -140.5 | 130 | 269.6 | 162.8 |
Income Tax Expense | 12.6 | 8.2 | -19.1 | 24.2 | 58 | 44.7 |
Earnings From Continuing Operations | 25.2 | -150.3 | -121.4 | 105.8 | 211.6 | 118.1 |
Earnings From Discontinued Operations | 28.8 | -16.8 | -308.9 | -111.2 | - | - |
Net Income to Company | 54 | -167.1 | -430.3 | -5.4 | 211.6 | 118.1 |
Net Income | 54 | -167.1 | -430.3 | -5.4 | 211.6 | 118.1 |
Net Income to Common | 54 | -167.1 | -430.3 | -5.4 | 211.6 | 118.1 |
Net Income Growth | - | - | - | - | 79.17% | -34.89% |
Shares Outstanding (Basic) | 35 | 36 | 36 | 36 | 38 | 40 |
Shares Outstanding (Diluted) | 36 | 36 | 36 | 37 | 38 | 40 |
Shares Change | -1.53% | -0.28% | -1.04% | -4.59% | -3.96% | -3.58% |
EPS (Basic) | 1.52 | -4.61 | -11.85 | -0.15 | 5.54 | 2.97 |
EPS (Diluted) | 1.51 | -4.61 | -11.85 | -0.15 | 5.50 | 2.95 |
EPS Growth | - | - | - | - | 86.44% | -32.49% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 154.9 | 273.5 | 51 | 95.3 | 170.9 | 189.5 |
Free Cash Flow Per Share | 4.32 | 7.55 | 1.40 | 2.60 | 4.44 | 4.73 |
Gross Margin | 41.13% | 39.53% | 39.26% | 38.30% | 34.23% | 36.85% |
Operating Margin | 24.52% | 22.42% | 24.07% | 22.88% | 20.52% | 22.09% |
Profit Margin | 4.65% | -14.31% | -35.85% | -0.44% | 12.68% | 8.49% |
Free Cash Flow Margin | 13.35% | 23.42% | 4.25% | 7.84% | 10.24% | 13.62% |
EBITDA | 372.6 | 358.1 | 397.2 | 400.9 | 451.2 | 417.3 |
EBITDA Margin | 32.11% | 30.67% | 33.10% | 32.98% | 27.05% | 29.99% |
D&A For EBITDA | 88.1 | 96.3 | 108.3 | 122.8 | 108.8 | 109.9 |
EBIT | 284.5 | 261.8 | 288.9 | 278.1 | 342.4 | 307.4 |
EBIT Margin | 24.52% | 22.42% | 24.07% | 22.88% | 20.52% | 22.09% |
Effective Tax Rate | 33.33% | - | - | 18.62% | 21.51% | 27.46% |